The Patent Finder

Compositions and Methods for the Treatment of Viral Infections (2021)

Cidara Therapeutics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 17/194,093, filed Mar 5, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,510,992Compositions and Methods for the Treatment of Viral Infections
In force
 · Medium confidence
UsedRemaining
Cidara Therapeutics, Inc.In forceMedium confidence
US 12,427,200Compositions and Methods for the Treatment of Viral Infections
In force
 · High confidence
Cidara Therapeutics, Inc.In forceHigh confidence
Application 17/194,093Compositions and Methods for the Treatment of Viral Infections
Abandoned
Abandoned Feb 18, 2022
Cidara Therapeutics, Inc.AbandonedAbandoned Feb 18, 2022
Application 19/277,976Compositions and Methods for the Treatment of Viral Infections
Pending
Not granted
Cidara Therapeutics, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Cidara Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited